ArticleFrontiers in pharmacology2025

Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system.

Wensheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.